Cboe has formally submitted 19b-4 filings to the U.S. Securities and Exchange Commission (SEC) seeking approval to list exchange-traded funds (ETFs) tied to staking rewards on the Solana and Injective blockchains. The proposed Invesco Galaxy Solana ETF and Canary Staked INJ ETF aim to provide investors with regulated exposure to cryptocurrency staking yields through traditional investment vehicles.
Cboe’s filings specifically request to list these products on its BZX Exchange platform under Rule 14.11, which permits trading products holding staked digital assets. The Canary Staked INJ ETF is structured to track Injective’s native token price while incorporating staking rewards, addressing accelerating institutional demand for blockchain-native yield strategies within compliant frameworks.
This regulatory initiative follows the SEC’s pivotal May 2025 ruling confirming cryptocurrency staking activities do not constitute securities violations. The commission is expected to deliver initial feedback on the filings by early September 2025, with a full review process that could extend up to 240 days under standard procedures.
If approved, these ETFs would streamline institutional access to blockchain-based yield generation mechanisms while adhering to U.S. securities regulations. The listings are poised to enhance market liquidity and broaden participation in cryptocurrency staking through regulated investment channels.